<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Gadopentetic acid MRI contrast agent Gadobenic acid Nephrogenic systemic fibrosis Pentetic acid Magnetic resonance imaging Contrast medium Gadoteridol Perfusion scanning Chemistry Matter Gadolinium |
| Prohance (gadoteridol) injection labelDocID: G7wG - View Document |
| AVAILABLE FOR PUBLIC DISCLOSURE WITHOUT REDACTION Page: 2 ofDocID: D2qm - View Document |
| U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archivedDocID: Cko2 - View Document |
| [removed]Gadobutrol Statistical PREADocID: BTRF - View Document |
| Microsoft Word - DDR letter - final with signatures[removed]mcm.docDocID: Bbtf - View Document |